Triptax

Triptax
Clinical data
Other namesTriptax™
Drug classUndefined

Triptax is a drug which is under development for the treatment of depressive disorders and treatment-resistant depression. Its mechanism of action has not been defined. The drug is being developed by Biomind Labs. As of December 2022, it is in the preclinical research stage of development. The chemical structure of Triptax does not yet seem to have been disclosed, but it is described as a new chemical entity. Aside from Triptax, Biomind Labs is also developing a variety of defined serotonergic agents and serotonergic psychedelics for treatment of various conditions.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.